Related references
Note: Only part of the references are listed.Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT?
Meinolf Suttorp et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia
Haruko Shima et al.
JOURNAL OF PEDIATRICS (2011)
Acquired Growth Hormone Deficiency in a Girl With Chronic Myelogenous Leukemia Treated With Tyrosine Kinase Inhibitor Therapy
Susan L. Hobernicht et al.
PEDIATRIC BLOOD & CANCER (2011)
Higher Dose Imatinib for Children With De Novo Chronic Phase Chronic Myelogenous Leukemia: A Report From the Children's Oncology Group
Martin A. Champagne et al.
PEDIATRIC BLOOD & CANCER (2011)
Outcome of 125 Children with Chronic Myelogenous Leukemia Who Received Transplants from Unrelated Donors: The Japan Marrow Donor Program
Hideki Muramatsu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Dysregulation of bone remodeling by imatinib mesylate
Kate Vandyke et al.
BLOOD (2010)
Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP
Panos Kanavos et al.
Globalization and Health (2010)
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
Meinolf Suttorp et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Longitudinal growth retardation in a prepubertal girl with chronic myeloid leukemia on long-term treatment with imatinib
Hansjoerg Schmid et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Growth deceleration in a girl treated with imatinib
Tomiko Kimoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Imatinib mesylate causes growth plate closure in vivo
K. Vandyke et al.
LEUKEMIA (2009)
Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?
L. Kebapcilar et al.
MEDICAL PRINCIPLES AND PRACTICE (2009)
Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT
M. Suttorp
BONE MARROW TRANSPLANTATION (2008)
Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty
Stefania Mariani et al.
LANCET (2008)
Altered bone and mineral metabolism in patients receiving imatinib mesylate
E Berman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?
J Goldman et al.
LEUKEMIA & LYMPHOMA (2006)
Share Paper
